Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer

Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer

US Patent 8288099 · Granted Oct 16, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Collector for detection and reversible capturing of cells from body fluids in vi2021
Molecular malignancy in melanocytic lesions2017
Utility of B-RAF DNA mutation in diagnosis and treatment of cancer2017
Utility of B-RAF DNA mutation in diagnosis and treatment of cancer2017
Long noncoding RNA (lncRNA) as a biomarker and therapeutic marker in cancer2016
Detection of cancer cells in body fluids2011
Utility of RET mutant in diagnosis and treatment of melanoma2011
Detection of micro metastasis of melanoma and breast cancer in paraffin-embedded2011
Molecular lymphatic mapping of sentinel lymph nodes2011
Use of ID4 for diagnosis and treatment of cancer2011
Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric can2010
Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric can2010